The synthesis of 19-nor-1α, 25-dihydroxy-22-oxo-vitamin D3

被引：0
|
作者：
Wu, Y
Guan, M
Li, PJ
Xu, C
Wu, XC
机构：
[1] W China Univ Med Sci, Sch Pharm, Chengdu 610041, Peoples R China
[2] W China Univ Med Sci, Hosp 1, Chengdu 610041, Peoples R China
来源：
CHINESE CHEMICAL LETTERS | 2001年 / 12卷 / 01期
关键词：
19-nor-1; alpha; 25-dihydroxy-22-oxo-vitamin D-3; device; synthesis;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
19-Nor-1 alpha, 25-dihydroxy-22-oxo-vitamin D-3 4 was synthesized by the coupling of known compound 5 and the A-ring phosphine oxide 6 followed by deprotection of the hydroxy functions.
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [31] 1α,25-Dihydroxy Vitamin D3 Induces Nuclear Matrix Association of the 1α,25-Dihydroxy Vitamin D3 Receptor in Osteoblasts Independently of Its Ability to Bind DNA
    Arriagada, Gloria
    Paredes, Roberto
    Van Wijnen, Andre J.
    Lian, Jane B.
    Van Zundert, Brigitte
    Stein, Gary S.
    Stein, Janet L.
    Montecino, Martin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 222 (02) : 336 - 346
  • [32] 1α,25-Dihydroxy vitamin D3, the active form of vitamin D3, protects against allergeninduced airway constriction
    Maarsingh, Harm
    Remick, Adam J.
    Stimson, David T. J.
    Lopez, Alejandro
    Bolson, Anthony
    DellaVecchia, Matthew
    FASEB JOURNAL, 2019, 33
  • [33] Lack of effect of hemodialysis on plasma concentrations of 19-nor-1 alpha,25-dihydroxy-vitamin D-2 (19-nor) allows dose administration without regard to dialysis.
    Cato, A
    Qasawa, B
    Chang, M
    Soltanek, C
    Stoll, R
    Cady, W
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2661 - A2661
  • [34] A single center double-blind placebo controlled randomized trial of 19-NOR-1 alpha-25-dihydroxy-vitamin D-2 (''19-NOR'') in patients on hemodialysis.
    Martin, KJ
    Gellens, ME
    Gonzalez, EA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : P308 - P308
  • [35] Evaluation of C-2-substituted 19-nor-1α,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer
    Chen, T. C.
    Persons, K. S.
    Zheng, S.
    Mathieu, J.
    Holick, M. F.
    Lee, Y. F.
    Bao, B.
    Arai, M. A.
    Kittaka, A.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5): : 717 - 720
  • [36] Coordinated effects of 1α,25-dihydroxy vitamin D3 on the immune response
    Burke, F
    Evans, KN
    Lammas, DA
    Hewison, M
    Sansom, DM
    IMMUNOLOGY, 2005, 116 : 103 - 103
  • [37] The Synthesis of an Optically Active Intermediate of A-Ring for 1α,25-Dihydroxy Vitamin D3 Analogs
    Yong WU
    and (School of Pharmacy
    ChineseChemicalLetters, 1998, (05) : 431 - 432
  • [38] The synthesis of an optically active intermediate of A-ring for 1α,25-dihydroxy vitamin D3 analogs
    Wu, Y
    Guan, M
    CHINESE CHEMICAL LETTERS, 1998, 9 (05) : 431 - 432
  • [39] 1α,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1α,25-dihydroxy vitamin D3:: production and biological activity studies in pulmonary alveolar type II cells
    Rehan, VK
    Torday, JS
    Peleg, S
    Gennaro, L
    Vouros, P
    Padbury, J
    Rao, DS
    Reddy, GS
    MOLECULAR GENETICS AND METABOLISM, 2002, 76 (01) : 46 - 56
  • [40] Synthesis of 2-Ethyl-19-nor Analogs of 1α,25-Dihydroxyvitamin D3
    Laplace, Duchan R.
    Van Overschelde, Michel
    De Clercq, Pierre J.
    Verstuyf, Annemieke
    Winne, Johan M.
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2013, 2013 (04) : 728 - 735
12345